|
According to the Nashua, N.H.-based company, the cancer detection product incorporates CAD lesion metrics to provide clinicians with enhanced clinical analysis and information. iCAD said it has 27 U.S. patents and 15 U.S. patent applications pending.
Last updated on March 9, 2010 at 10:10 am EST
|